Head-to-head comparisons of medication uses, side effects, warnings, and more.
Mresvia
Arexvy (RSV vaccine)
Mresvia
Arexvy (RSV vaccine)
Summary of Mresvia vs. Arexvy
Summary for Vaccine
Prescription only
MRESVIA is an mRNA vaccine that's used to protect adults 60 years and older from illness caused by respiratory syncytial virus (RSV). This vaccine is injected into the muscle by a trained healthcare professional (HCP), and you only need to get one dose. Some potential side effects of the MRESVIA RSV vaccine include pain at the injection site, tiredness, headache, and muscle pain.
Summary for Vaccine
Prescription only
Arexvy (RSV vaccine) is a FDA-approved vaccine used to lower the risk of illness caused by respiratory syncytial virus (RSV). It's the first RSV vaccine approved in the United States. You can receive Arexvy (RSV vaccine) if you're age 60 years or older, and in some cases, starting at age 50 if you're at high risk for serious problems if infected. But first, you should discuss the risks and benefits with your primary care provider. Arexvy (RSV vaccine) is given once as a shot into the muscle, typically in your upper arm. Common side effects of this vaccine include injection site reactions, headache, joint and muscle aches, and feeling tired.